JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB47574

Anti-Chk1 antibody

3

(3 Reviews)

|

(30 Publications)

Rabbit Polyclonal CHK1 antibody. Suitable for WB, IHC-P and reacts with Human samples. Cited in 30 publications. Immunogen corresponding to Synthetic Peptide within Human CHEK1.

View Alternative Names

CHK1, CHEK1, Serine/threonine-protein kinase Chk1, CHK1 checkpoint homolog, Cell cycle checkpoint kinase, Checkpoint kinase-1

2 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Chk1 antibody (AB47574)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Chk1 antibody (AB47574)

ab47574 staining Chk1 in Human heart.
Left panel : with primary antibody at 4 ug/ml. Right panel : isotype control.
Sections were stained using an automated system (DAKO Autostainer Plus), at room temperature : sections were rehydrated and antigen retrieved with the Dako 3 in 1 AR buffers EDTA pH 9.0. Slides were peroxidase blocked in 3% H2O2 in methanol for 10 mins. They were then blocked with Dako Protein block for 10 minutes (containing casein 0.25% in PBS) then incubated with primary antibody for 20 min and detected with Dako envision flex amplification kit for 30 minutes. Colorimetric detection was completed with Diaminobenzidine for 5 minutes. Slides were counterstained with Haematoxylin and coverslipped under DePeX. Please note that for manual staining we recommend to optimize the primary antibody concentration and incubation time (overnight incubation), and amplification may be required.

Western blot - Anti-Chk1 antibody (AB47574)
  • WB

Unknown

Western blot - Anti-Chk1 antibody (AB47574)

Secondary antibody - anti-rabbit HRP (ab6721)

All lanes:

Western blot - Anti-Chk1 antibody (ab47574) at 1/500 dilution

Lane 1:

HT29 cell extract treated with UV. No peptide.

Lane 2:

HT29 cell extract treated with UV. Synthetic peptide present.

Predicted band size: 54 kDa

Observed band size: 54 kDa

false

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

WB, IHC-P

applications

Immunogen

Synthetic Peptide within Human CHEK1. The exact immunogen used to generate this antibody is proprietary information.

O14757

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "", "WB-species-notes": "<p></p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "4 µg/mL", "IHCP-species-notes": "<p></p>" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Immunogen
Purification notes
The antibody was affinity purified from rabbit antiserum by affinity chromatography using epitope specific immunogen.
Storage buffer
pH: 7.4 Preservative: 0.02% Sodium azide Constituents: PBS, 50% Glycerol (glycerin, glycerine), 0.87% Sodium chloride
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Storage information
Stable for 12 months at -20°C

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Serine/threonine-protein kinase which is required for checkpoint-mediated cell cycle arrest and activation of DNA repair in response to the presence of DNA damage or unreplicated DNA (PubMed : 11535615, PubMed : 12399544, PubMed : 12446774, PubMed : 14559997, PubMed : 14988723, PubMed : 15311285, PubMed : 15650047, PubMed : 15665856, PubMed : 32357935). May also negatively regulate cell cycle progression during unperturbed cell cycles (PubMed : 11535615, PubMed : 12399544, PubMed : 12446774, PubMed : 14559997, PubMed : 14988723, PubMed : 15311285, PubMed : 15650047, PubMed : 15665856). This regulation is achieved by a number of mechanisms that together help to preserve the integrity of the genome (PubMed : 11535615, PubMed : 12399544, PubMed : 12446774, PubMed : 14559997, PubMed : 14988723, PubMed : 15311285, PubMed : 15650047, PubMed : 15665856). Recognizes the substrate consensus sequence [R-X-X-S/T] (PubMed : 11535615, PubMed : 12399544, PubMed : 12446774, PubMed : 14559997, PubMed : 14988723, PubMed : 15311285, PubMed : 15650047, PubMed : 15665856). Binds to and phosphorylates CDC25A, CDC25B and CDC25C (PubMed : 12676583, PubMed : 12676925, PubMed : 12759351, PubMed : 14559997, PubMed : 14681206, PubMed : 19734889, PubMed : 9278511). Phosphorylation of CDC25A at 'Ser-178' and 'Thr-507' and phosphorylation of CDC25C at 'Ser-216' creates binding sites for 14-3-3 proteins which inhibit CDC25A and CDC25C (PubMed : 9278511). Phosphorylation of CDC25A at 'Ser-76', 'Ser-124', 'Ser-178', 'Ser-279' and 'Ser-293' promotes proteolysis of CDC25A (PubMed : 12676583, PubMed : 12676925, PubMed : 12759351, PubMed : 14681206, PubMed : 19734889, PubMed : 9278511). Phosphorylation of CDC25A at 'Ser-76' primes the protein for subsequent phosphorylation at 'Ser-79', 'Ser-82' and 'Ser-88' by NEK11, which is required for polyubiquitination and degradation of CDCD25A (PubMed : 19734889, PubMed : 20090422, PubMed : 9278511). Inhibition of CDC25 leads to increased inhibitory tyrosine phosphorylation of CDK-cyclin complexes and blocks cell cycle progression (PubMed : 9278511). Also phosphorylates NEK6 (PubMed : 18728393). Binds to and phosphorylates RAD51 at 'Thr-309', which promotes the release of RAD51 from BRCA2 and enhances the association of RAD51 with chromatin, thereby promoting DNA repair by homologous recombination (PubMed : 15665856). Phosphorylates multiple sites within the C-terminus of TP53, which promotes activation of TP53 by acetylation and promotes cell cycle arrest and suppression of cellular proliferation (PubMed : 10673501, PubMed : 15659650, PubMed : 16511572). Also promotes repair of DNA cross-links through phosphorylation of FANCE (PubMed : 17296736). Binds to and phosphorylates TLK1 at 'Ser-743', which prevents the TLK1-dependent phosphorylation of the chromatin assembly factor ASF1A (PubMed : 12660173, PubMed : 12955071). This may enhance chromatin assembly both in the presence or absence of DNA damage (PubMed : 12660173, PubMed : 12955071). May also play a role in replication fork maintenance through regulation of PCNA (PubMed : 18451105). May regulate the transcription of genes that regulate cell-cycle progression through the phosphorylation of histones (By similarity). Phosphorylates histone H3.1 (to form H3T11ph), which leads to epigenetic inhibition of a subset of genes (By similarity). May also phosphorylate RB1 to promote its interaction with the E2F family of transcription factors and subsequent cell cycle arrest (PubMed : 17380128). Phosphorylates SPRTN, promoting SPRTN recruitment to chromatin (PubMed : 31316063). Reduces replication stress and activates the G2/M checkpoint, by phosphorylating and inactivating PABIR1/FAM122A and promoting the serine/threonine-protein phosphatase 2A-mediated dephosphorylation and stabilization of WEE1 levels and activity (PubMed : 33108758).. Isoform 2. Endogenous repressor of isoform 1, interacts with, and antagonizes CHK1 to promote the S to G2/M phase transition.
See full target information CHEK1

Publications (30)

Recent publications for all applications. Explore the full list and refine your search

iScience 27:108925 PubMed38323009

2024

RNA helicase DDX3 regulates RAD51 localization and DNA damage repair in Ewing sarcoma.

Applications

Unspecified application

Species

Unspecified reactive species

Matthew E Randolph,Marwa Afifi,Aparna Gorthi,Rachel Weil,Breelyn A Wilky,Joshua Weinreb,Paul Ciero,Natalie Ter Hoeve,Paul J van Diest,Venu Raman,Alexander J R Bishop,David M Loeb

Journal of clinical medicine 11: PubMed35160302

2022

Cyclin D1 Binding Protein 1 Responds to DNA Damage through the ATM-CHK2 Pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Yusuke Niwa,Kenya Kamimura,Kohei Ogawa,Chiyumi Oda,Yuto Tanaka,Ryoko Horigome,Masato Ohtsuka,Hiromi Miura,Koichi Fujisawa,Naoki Yamamoto,Taro Takami,Shujiro Okuda,Masayoshi Ko,Takashi Owaki,Atsushi Kimura,Osamu Shibata,Shinichi Morita,Norihiro Sakai,Hiroyuki Abe,Takeshi Yokoo,Akira Sakamaki,Hiroteru Kamimura,Shuji Terai

Cancer science 113:132-144 PubMed34668620

2021

P90 ribosomal S6 kinase confers cancer cell survival by mediating checkpoint kinase 1 degradation in response to glucose stress.

Applications

Unspecified application

Species

Unspecified reactive species

Ying Ma,Danrui Cui,Linchen Wang,Yue Wang,Fei Yang,Hui Pan,Longyuan Gong,Minrun Zhang,Xiufang Xiong,Yongchao Zhao

Biochemical and biophysical research communications 579:141-145 PubMed34600299

2021

SARS-CoV-2 triggers DNA damage response in Vero E6 cells.

Applications

Unspecified application

Species

Unspecified reactive species

Joshua Victor,Jamie Deutsch,Annalis Whitaker,Erica N Lamkin,Anthony March,Pei Zhou,Jason W Botten,Nimrat Chatterjee

Nature communications 12:3127 PubMed34035299

2021

Cornelia de Lange syndrome-associated mutations cause a DNA damage signalling and repair defect.

Applications

Unspecified application

Species

Unspecified reactive species

Gabrielle Olley,Madapura M Pradeepa,Graeme R Grimes,Sandra Piquet,Sophie E Polo,David R FitzPatrick,Wendy A Bickmore,Charlene Boumendil

Scientific reports 10:7488 PubMed32366852

2020

ATR Inhibition Broadly Sensitizes Soft-Tissue Sarcoma Cells to Chemotherapy Independent of Alternative Lengthening Telomere (ALT) Status.

Applications

Unspecified application

Species

Unspecified reactive species

Audrey Laroche-Clary,Vanessa Chaire,Stéphanie Verbeke,Marie-Paule Algéo,Andrei Malykh,François Le Loarer,Antoine Italiano

Journal of hematology & oncology 13:40 PubMed32357935

2020

Ubiquitination of the DNA-damage checkpoint kinase CHK1 by TRAF4 is required for CHK1 activation.

Applications

Unspecified application

Species

Unspecified reactive species

Xinfang Yu,Wei Li,Haidan Liu,Qipan Deng,Xu Wang,Hui Hu,Zijun Y Xu-Monette,Wei Xiong,Zhongxin Lu,Ken H Young,Wei Wang,Yong Li

Nature communications 11:1755 PubMed32273511

2020

p53-mediated control of aspartate-asparagine homeostasis dictates LKB1 activity and modulates cell survival.

Applications

Unspecified application

Species

Unspecified reactive species

Longfei Deng,Pengbo Yao,Le Li,Fansen Ji,Shuang Zhao,Chang Xu,Xun Lan,Peng Jiang

Cellular microbiology 21:e13076 PubMed31254473

2019

Bacterial quorum-sensing signal IQS induces host cell apoptosis by targeting POT1-p53 signalling pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Jianhe Wang,Chao Wang,Hong-Bing Yu,Stephen Dela Ahator,Xiaoyan Wu,Shumei Lv,Lian-Hui Zhang

Cancer management and research 11:4655-4668 PubMed31213891

2019

Estrogen-dependent disruption of intracellular iron metabolism augments the cytotoxic effects of doxorubicin in select breast and ovarian cancer cells.

Applications

Unspecified application

Species

Unspecified reactive species

Khuloud Bajbouj,Jasmin Shafarin,Mawieh Hamad
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com